GETINGE Revenue 2016-2023 | GNGBY
GETINGE Annual Revenue (Millions of US $) |
|
---|---|
2023 | $3,001 |
2022 | $2,804 |
2021 | $3,154 |
2020 | $3,250 |
2019 | $2,810 |
2018 | $2,782 |
2017 | $2,639 |
2016 | $3,478 |
2015 | $3,586 |
GETINGE Quarterly Revenue (Millions of US $) |
|
---|---|
2023-09-30 | $704 |
2023-06-30 | $682 |
2023-03-31 | $683 |
2022-12-31 | $805 |
2022-09-30 | $659 |
2022-06-30 | $678 |
2022-03-31 | $662 |
2021-12-31 | $906 |
2021-09-30 | $730 |
2021-06-30 | $783 |
2021-03-31 | $735 |
2020-12-31 | $1,005 |
2020-09-30 | $900 |
2020-06-30 | $721 |
2020-03-31 | $625 |
2019-12-31 | $888 |
2019-09-30 | $651 |
2019-06-30 | $665 |
2019-03-31 | $605 |
2018-12-31 | $884 |
2018-09-30 | $635 |
2018-06-30 | $662 |
2018-03-31 | $601 |
2017-12-31 | $245 |
2017-09-30 | $824 |
2017-06-30 | $823 |
2017-03-31 | $747 |
2016-12-31 | $1,066 |
2016-09-30 | $813 |
2016-06-30 | $844 |
2016-03-31 | $755 |
2015-12-31 | $1,107 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $0.000B | $3.000B |
Getinge AB develops, manufactures and sells products and services for operating rooms, intensive-care units, hospital wards, sterilization departments, elderly care for life science companies and institutions. The company's operating segments consists of Medical Systems, Extended Care and Infection Control. It operates primarily in the United Kingdom, France, the United States and Australia. Getinge AB is headquartered in Gothenburg, Sweden. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Elevance Health (ELV) | United States | $123.697B | 15.52 |
Cencora (COR) | United States | $47.247B | 18.86 |
ICON (ICLR) | Ireland | $24.578B | 24.24 |
DiDi Global (DIDIY) | China | $22.930B | 0.00 |
Avantor (AVTR) | United States | $16.557B | 22.81 |
CochLear (CHEOY) | $13.675B | 0.00 | |
Viatris (VTRS) | United States | $13.496B | 3.85 |
Revvity (RVTY) | United States | $12.448B | 21.67 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $12.029B | 0.00 |
Charles River Laboratories (CRL) | United States | $11.979B | 21.84 |
Medpace Holdings (MEDP) | United States | $11.658B | 38.35 |
Solventum (SOLV) | United States | $10.708B | 0.00 |
Natera (NTRA) | United States | $10.700B | 0.00 |
Amplifon S.p.A (AMFPF) | Italy | $7.290B | 37.01 |
HealthEquity (HQY) | United States | $6.966B | 52.04 |
Bausch + Lomb (BLCO) | Canada | $5.145B | 19.78 |
Doximity (DOCS) | United States | $4.625B | 34.43 |
Organon (OGN) | United States | $4.601B | 4.46 |
PACS (PACS) | United States | $3.460B | 0.00 |
Progyny (PGNY) | United States | $3.177B | 53.32 |
Sotera Health (SHC) | United States | $3.139B | 15.40 |
Surgery Partners (SGRY) | United States | $3.044B | 28.28 |
Life Times (LTH) | United States | $2.774B | 30.65 |
GoodRx Holdings (GDRX) | United States | $2.631B | 133.20 |
Premier (PINC) | United States | $2.522B | 9.23 |
Teladoc Health (TDOC) | United States | $2.252B | 0.00 |
AMN Healthcare Services Inc (AMN) | United States | $2.141B | 6.93 |
Agilon Health (AGL) | United States | $2.121B | 0.00 |
BrightSpring Health Services (BTSG) | United States | $1.816B | 0.00 |
Agiliti (AGTI) | United States | $1.368B | 22.33 |
Establishment Labs Holdings (ESTA) | $1.325B | 0.00 | |
NovoCure (NVCR) | Jersey | $1.273B | 0.00 |
Alignment Healthcare (ALHC) | United States | $0.947B | 0.00 |
Pediatrix Medical (MD) | United States | $0.759B | 7.85 |
Embecta (EMBC) | United States | $0.617B | 4.08 |
InnovAge Holding (INNV) | United States | $0.548B | 0.00 |
COMPASS Pathways (CMPS) | United Kingdom | $0.518B | 0.00 |
Enhabit (EHAB) | United States | $0.515B | 46.64 |
Auna S.A (AUNA) | Luxembourg | $0.466B | 0.00 |
CareDx (CDNA) | United States | $0.423B | 0.00 |
LifeMD (LFMD) | United States | $0.404B | 0.00 |
Beauty Health (SKIN) | United States | $0.404B | 0.00 |
Sonida Senior Living (SNDA) | United States | $0.395B | 0.00 |
DocGo (DCGO) | United States | $0.366B | 58.50 |
MultiPlan (MPLN) | United States | $0.356B | 0.00 |
Sera Prognostics (SERA) | United States | $0.317B | 0.00 |
ModivCare (MODV) | United States | $0.312B | 4.14 |
GeneDx Holdings (WGS) | United States | $0.271B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.260B | 0.00 |
Sharecare (SHCR) | United States | $0.250B | 0.00 |
So-Young (SY) | China | $0.131B | 44.00 |
Biodesix (BDSX) | United States | $0.125B | 0.00 |
Oncology Institute (TOI) | United States | $0.084B | 0.00 |
Pono Capital Two (PTWO) | United States | $0.063B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.056B | 0.00 |
NeueHealth (NEUE) | United States | $0.052B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.036B | 0.00 |
Nutex Health (NUTX) | United States | $0.034B | 0.00 |
Singular Genomics Systems (OMIC) | United States | $0.030B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.024B | 0.00 |
OncoCyte (OCX) | United States | $0.021B | 0.00 |
DermTech (DMTK) | United States | $0.021B | 0.00 |
BIMI Holdings (BIMI) | United States | $0.013B | 0.00 |
Aesthetic Medical Hldngs Group (AIH) | China | $0.012B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
TRxADE HEALTH (MEDS) | United States | $0.008B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
OpGen (OPGN) | United States | $0.008B | 0.00 |
XWELL (XWEL) | United States | $0.006B | 0.00 |
NewGenIvf Group (NIVF) | Singapore | $0.005B | 0.00 |
Assure Holdings (IONM) | United States | $0.004B | 0.00 |
ISpecimen (ISPC) | United States | $0.003B | 0.00 |
Aclarion (ACON) | United States | $0.002B | 0.00 |